Intraspinal MDL28170 Microinjection Improves Functional and Pathological Outcome following Spinal Cord Injury
Authors:
- 1 July 2008
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 25 (7) , 833-840
Abstract
Although calpain (calcium-activated cysteine protease) inhibition represents a rational therapeutic target for spinal cord injury (SCI), few studies have reported improved functional outcomes with post-injury administration of calpain inhibitors. This reflects the weak potency and limited aqueous solubility of current calpain inhibitors. Previously, we demonstrated that intraspinal microinjection of the calpain inhibitor MDL28170 resulted in greater inhibition of calpain activity as compared to systemic administration of the same compound. In the present study, we evaluated the ability of intraspinal MDL28170 microinjection to spare spinal tissue and locomotor dysfunction following SCI. Contusion SCI was produced in female Long-Evans rats using the Infinite Horizon impactor at the 200-kdyn force setting. Open-field locomotion was evaluated until 6 weeks post-injury. Histological assessment of tissue sparing was performed at 6 weeks after SCI. The results demonstrate that MDL28170, administered with a single post-injury intraspinal microinjection (50 nmoles), significantly improves both locomotor function and pathological outcome measures following SCI.Keywords
This publication has 45 references indexed in Scilit:
- Fas and Fas-Associated Death Domain Protein Regulate Monocyte Chemoattractant Protein-1 Expression by Human Smooth Muscle Cells Through Caspase- and Calpain-Dependent Release of Interleukin-1αCirculation Research, 2003
- Evaluation of Conditions for Calpain Inhibition in the Rat Spinal Cord: Effective Postinjury Inhibition with Intraspinal MDL28170 MicroinjectionJournal of Neurotrauma, 2003
- Cyclosporin A Treatment Following Spinal Cord Injury to the Rat: Behavioral Effects and Stereological Assessment of Tissue SparingJournal of Neurotrauma, 2001
- Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTENOncogene, 2001
- Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesionJournal of Neuroscience Research, 2000
- Pretreatment with Calpain Inhibitor CEP‐4143 Inhibits Calpain I Activation and Cytoskeletal Degradation, Improves Neurological Function, and Enhances Axonal Survival After Traumatic Spinal Cord InjuryJournal of Neurochemistry, 2000
- Behavioral Efficacy of Posttraumatic Calpain Inhibition is Not Accompanied by Reduced Spectrin Proteolysis, Cortical Lesion, or ApoptosisJournal of Cerebral Blood Flow & Metabolism, 2000
- LFA-1–mediated Adhesion Is Regulated by Cytoskeletal Restraint and by a Ca2+-dependent Protease, CalpainJournal of Cell Biology, 1998
- New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitroJournal of Neuroscience Research, 1998
- Delayed Antagonism of Calpain Reduces Excitotoxicity in Cultured NeuronsStroke, 1995